SCHEMBL7826786

SCHEMBL7826786

Cc1oc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1C(=O)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.54
GPR35 Q9HC97 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
JAK2 O60674 2/20 0.40
TYK2 P29597 2/20 0.40
THRB P10828 1/20 0.40
GHSR Q92847 2/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.38
JAK1 P23458 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7826306 0.83 GAA (0.45) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7831834 0.82 SMN1; SMN2 (0.42) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7823424 0.81 TSHR (0.41) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7828350 0.81 TP53 (0.41) GPR35ALDH1A1MAPTTP53SMN1; SMN2
SCHEMBL7831814 0.81 RAB9A (0.42) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7823933 0.80 MAPT (0.48) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7828069 0.80 GPR35 (0.46) CYP2C19GPR35ALDH1A1LMNAMAPT
SCHEMBL8341922 0.80 GPR35 (0.42) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7826421 0.79 ACHE (0.42) GPR35ALDH1A1LMNAMAPTNPSR1
SCHEMBL7817291 0.79 RAB9A (0.41) ALDH1A1LMNAMAPTNPSR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757682-B1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO (JP) 2001-06-20 EP disclosed
US-5858995-A ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-01-12 US disclosed
EP-0757682-A1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-12 EP disclosed
WO-1995029907-A1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-11-09 WO disclosed